| Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer V Noronha, VM Patil, A Joshi, N Menon, A Chougule, A Mahajan, A Janu, ... Journal of Clinical Oncology 38 (2), 124-136, 2020 | 421 | 2020 |
| Low-dose immunotherapy in head and neck cancer: a randomized study VM Patil, V Noronha, N Menon, R Rai, A Bhattacharjee, A Singh, ... Journal of Clinical Oncology 41 (2), 222-232, 2023 | 126 | 2023 |
| Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 … A Dasgupta, T Gupta, S Pungavkar, N Shirsat, S Epari, G Chinnaswamy, ... Neuro-oncology 21 (1), 115-124, 2019 | 77 | 2019 |
| Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma VM Patil, V Noronha, A Joshi, AB Choughule, A Bhattacharjee, R Kumar, ... ESMO open 2 (1), e000168, 2017 | 75 | 2017 |
| EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas? A Joshi, S Zanwar, V Noronha, VM Patil, A Chougule, R Kumar, A Janu, ... OncoTargets and therapy, 1859-1863, 2017 | 69 | 2017 |
| Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer … V Noronha, A Joshi, VM Patil, A Chougule, A Mahajan, A Janu, ... Journal of Clinical Oncology 37 (15_suppl), 9001-9001, 2019 | 41 | 2019 |
| Combined motor evoked potential monitoring and subcortical dynamic mapping in motor eloquent tumors allows safer and extended resections A Moiyadi, P Velayutham, P Shetty, K Seidel, A Janu, V Madhugiri, ... World neurosurgery 120, e259-e268, 2018 | 39 | 2018 |
| The importance of brain metastasis in EGFR mutation positive NSCLC patients V Noronha, A Joshi, A Gokarn, V Sharma, V Patil, A Janu, N Purandare, ... Chemotherapy research and practice 2014 (1), 856156, 2014 | 37 | 2014 |
| ALK positive lung cancer: clinical profile, practice and outcomes in a developing country V Noronha, A Ramaswamy, VM Patil, A Joshi, A Chougule, S Kane, ... PLoS One 11 (9), e0160752, 2016 | 35 | 2016 |
| ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes A Joshi, N Pande, V Noronha, V Patil, R Kumar, A Chougule, V Trivedi, ... Ecancermedicalscience 13, 2019 | 32 | 2019 |
| Utility of flouro-deoxy-glucose positron emission tomography/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma M Gupta, T Gupta, N Purandare, V Rangarajan, A Puranik, A Moiyadi, ... CNS oncology 8 (4), CNS46, 2019 | 31 | 2019 |
| A real‐world data of Immune checkpoint inhibitors in solid tumors from India V Noronha, G Abraham, V Patil, A Joshi, N Menon, A Mahajan, A Janu, ... Cancer Medicine 10 (5), 1525-1534, 2021 | 29 | 2021 |
| Carcinoma cuniculatum of the oral cavity: a series of 6 cases and review of literature S Yadav, M Bal, S Rane, N Mittal, A Janu, A Patil Head and Neck Pathology 16 (1), 213-223, 2022 | 22 | 2022 |
| Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma VM Patil, A Bhelekar, N Menon, A Bhattacharjee, V Simha, R Abhinav, ... Cancer Medicine 9 (13), 4676-4685, 2020 | 20 | 2020 |
| Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes J Bajpai, N Khanna, T Vora, A Gulia, S Laskar, A Puri, B Sanduptla, ... Indian Journal of Cancer 55 (1), 37-44, 2018 | 20 | 2018 |
| Radiation therapy dose escalation in unresectable Ewing sarcoma: Final results of a phase 3 randomized controlled trial S Laskar, S Sinha, A Chatterjee, N Khanna, JJ Manjali, A Puri, A Gulia, ... International Journal of Radiation Oncology* Biology* Physics 113 (5), 996-1002, 2022 | 17 | 2022 |
| CT-guided radiofrequency ablation in osteoid osteoma: Result from a tertiary cancer centre in India SS Kulkarni, NS Shetty, AM Polnaya, A Janu, S Kumar, A Puri, A Gulia, ... Indian Journal of Radiology and Imaging 27 (03), 318-323, 2017 | 17 | 2017 |
| Adapting management of sarcomas in COVID-19: an evidence-based review A Gulia, RS Arora, PK Panda, A Raja, A Tiwari, S Bakhshi, N Salins, ... Indian Journal of Orthopaedics 55, 1-13, 2021 | 14 | 2021 |
| Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma R Krishnatry, JJ Manjali, G Chinnaswamy, A Chatterjee, JS Goda, A Janu, ... Japanese Journal of Clinical Oncology 51 (5), 762-768, 2021 | 13 | 2021 |
| Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patients S Zanwar, V Noronha, A Joshi, VM Patil, A Chougule, R Kumar, S More, ... Indian Journal of Cancer 54 (1), 280-284, 2017 | 13 | 2017 |